C

Cellectar Biosciences
D

CLRB

5.09000
USD
-0.18
(-3.42%)
مغلق
حجم التداول
6,730
الربح لكل سهم
-15
العائد الربحي
-
P/E
-0
حجم السوق
14,542,329
أصول ذات صلة
A
ADVM
0.03000
(1.12%)
2.71000 USD
A
AGEN
-0.11000
(-1.82%)
5.94500 USD
A
ARWR
-0.520
(-3.20%)
15.740 USD
C
CRBP
0.18000
(2.00%)
9.17000 USD
C
CVM
1.20200
(17.22%)
8.18200 USD
M
MNOV
0.21500
(17.27%)
1.46000 USD
المزيد
الأخبار المقالات

العنوان: Cellectar Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.